Clinical applications of dendritic cells–cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis

References

• ChenJGuoXZQiXSClinical outcomes of specific immunotherapy in advanced pancreatic cancer: a systematic review and meta-analysisJ Immunol Res20172017116
   Web of Science ®Google Scholar
• ThindKPadrnosLJRamanathanRKBoradMJImmunotherapy in pancreatic cancer treatment: a new frontierTherap Adv Gastroenterol2017101168194
   PubMedGoogle Scholar
• ChenLZhangXPrimary analysis for clinical efficacy of immunotherapy in patients with pancreatic cancerImmunotherapy20168222323426565954
   PubMed Web of Science ®Google Scholar
• ChangJHJiangYPillarisettyVGRole of immune cells in pancreatic cancer from bench to clinical application: an updated reviewMedicine (Baltimore)20169549e554127930550
   PubMedGoogle Scholar
• ZhangLMuYZhangACytokine-induced killer cells/dendritic cells–cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patientsOncotarget2017828451644517728404886
   PubMedGoogle Scholar
• ZhouCLiuDLiJChemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: a meta-analysisOncotarget2016752865008651027863436
   PubMedGoogle Scholar
• DillmanRODumaCMEllisRAIntralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastomaJ Immunother200932991491919816190
   PubMedGoogle Scholar
• YamaguchiYHiharaJHironakaKPostoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndromeOncol Rep200615489590116525677
   PubMed Web of Science ®Google Scholar
• YangYLimOKimTMPhase I study of random healthy donor-derived allogeneic natural killer cell therapy in patients with malignant lymphoma or advanced solid tumorsCancer Immunol Res20164321522426787822
   PubMedGoogle Scholar
• ZhaoZLiaoHJuYEffect of compound Kushen injection on T-cell subgroups and natural killer cells in patients with locally advanced non-small-cell lung cancer treated with concomitant radiochemotherapyJ Tradit Chin Med2016361141826946613
   PubMedGoogle Scholar
• DudleyMEGrossCASomervilleRPRandomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanomaJ Clin Oncol201331172152215923650429
   PubMed Web of Science ®Google Scholar
• KageyamaSIkedaHMiyaharaYAdoptive transfer of MAGE-A4 T-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal cancerClin Cancer Res201521102268227725855804
   PubMedGoogle Scholar
• MuYZhouCHChenSFEffectiveness and safety of chemotherapy combined with cytokine-induced killer cell/dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: a systematic review and meta-analysisCytotherapy20161891162117727421742
   PubMed Web of Science ®Google Scholar
• WangZXCaoJXWangMAdoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysisCytotherapy201416793494524794183
   PubMed Web of Science ®Google Scholar
• LiuYMuYZhangACytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysisOnco Targets Ther2017101897190828408841
   PubMed Web of Science ®Google Scholar
• WangMShiSBQiJLTangXYTianJS-1 plus CIK as second-line treatment for advanced pancreatic cancerMed Oncol201330474724122257
   PubMedGoogle Scholar
• WangZLiuYLiRAutologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancerJ Hematol Oncol201691626842696
   PubMedGoogle Scholar
• ChungMJParkJYBangSParkSWSongSYPhase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancerCancer Immunol Immunother201463993994624916038
   PubMed Web of Science ®Google Scholar
• LiWWangYKellnerDBXuLMaiLEfficacy of cytokine-induced killer cells in the treatment of elderly patients with metastatic pancreatic adenocarcinomaCent Eur J Immunol201540218819326557033
   PubMedGoogle Scholar
• ZengXZhangYKwongJSThe methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic reviewJ Evid Based Med20158121025594108
   PubMedGoogle Scholar
• HanRXLiuXPanPJiaYJYuJCEffectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysisPLoS One201499e10895825268709
   PubMed Web of Science ®Google Scholar
• JacksonDWhiteIRRileyRDQuantifying the impact of between-study heterogeneity in multivariate meta-analysesStat Med201231293805382022763950
   PubMed Web of Science ®Google Scholar
• CaiXRLiXLinJXAutologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic reviewOncotarget2017819313183132828412743
   PubMedGoogle Scholar
• GeJNGeCLEffect of DC–CIK cells on immune function in patients with pancreatic cancer after chemotherapyJ Community Med201614172627
   Google Scholar
• KangJZhangHYClinical analysis of gemcitabine chemotherapy coast CIK cell treatment of pancreatic cancerChina Contin Med Educ201685141142
   Google Scholar
• LiXDClinical observation of three dimensional conformal radiotherapy concurrent with chemotherapy combined with autologous cytokine induced killer cell immunotherapy for treatment of locally advanced pancreatic cancerChina Clin Prac Med2016726466
   Google Scholar
• LiuAHInfluence of chemotherapy combined with DC–CIK cell on the immune function in patients with pancreatic cancerChin J Clin201262063016305
   Google Scholar
• MuLZhongXPLiuHMClinical efficacy evaluation of DC–CIK in the treatment of advanced pancreatic cancer after chemotherapyGuizhou Med J2016405532535
   Google Scholar
• ShenDLiuTLinQFClinical evaluation of cytokine-induced killer cells combination with chemotherapy in patients with advanced pancreatic cancerJ Prac Med2015311321482151
   Google Scholar
• WangJEffects of gemcitabine chemotherapy combined with CIK cells therapy in the treatment of pancreatic cancerMed Pharm Yunnan2015362183185
   Google Scholar
• WenQXZhuYXuBWangMFThe study of clinical application of DC–CIK combined with chemotherapy on advanced pancreatic cancerMod J Integr Trad Chin West Med2013223640654066
   Google Scholar
• ZhangYHWangMHTianYXuFClinical research of patients with advanced pancreatic cancer treated with CIK cells combined with chemotherapyJ Basic Clin Oncol2013264317319
   Google Scholar
• ZhangYLStudy of the influence on immunologic balance and clinical effect by chemotherapy combined with DC–CIK cell to patients with pancreatic cancerChina J Mod Med20142494245
   Google Scholar
• ZhangZQWangZYZhengSWangXZHeLJEffect of DC–CIK cell therapy on immune function and clinical efficacy analysis of DC–CIK for treatment of pancreatic cancer after chemotherapyChina Prac Med2016117183184
   Google Scholar
• ZhengCYinYLJinHFLiuHQEffect of chemotherapy combined with DC–CIK cell therapy on immune function in patients with pancreatic cancerBao Jian Wen Hui20166153
   Google Scholar
• LiuHLiJWangFComparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinomaTumour Biol20153642299230725417201
   PubMedGoogle Scholar